EGFR and hepatocellular carcinoma: Network pharmacology analysis described above suggested that the PI3K/AKT, EGFR, MAPK, and NFκB signaling pathway may be highly related to the anti-cancer mechanism of SO on HCC in regulating HCC cell proliferation and survival.